1-8 of 8

Search Results for fda

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Article
South Atlantic Quarterly (1975) 74 (3): 308–323.
Published: 01 July 1975
...," in Amphetamine Abuse, ed. J. Robert Russo (Springfield. III., 1968). 17. "Students Warned Against Pep Pills at Examinations," Sci. NL, 31 (12 June 1937), 377; Memo of Interview, H. B. Fisher and Dr. C. N. Lewis, 28 March 1940, Box 27. FDA Decimal File 511.09, Accession 59A-2736, Records Group 88, Washington...
Journal Article
South Atlantic Quarterly (1981) 80 (4): 379–390.
Published: 01 October 1981
...-medication products. In 1972 the FDA set in motion machinery for achieving this result. To reconsider each of the hundreds of thousands nobody knew how many proprietary remedies seemed sheer madness. By that route, in the Supreme Court s phrase, only paralysis would result. So the FDA determined...
Journal Article
South Atlantic Quarterly (1975) 74 (2): 273–274.
Published: 01 April 1975
... of a reasonable certainty that no harm will result from eat­ ing the proposed additive. And yet there is the case of the red dye, FD&C Red No. 2, which is used to color innumerable foods. In No­ vember 1971 the FDA scientists decided that the evidence for carci­ nogenesis in animals following administration...
Journal Article
South Atlantic Quarterly (1975) 74 (2): 274–275.
Published: 01 April 1975
... must show proof of a reasonable certainty that no harm will result from eat­ ing the proposed additive. And yet there is the case of the red dye, FD&C Red No. 2, which is used to color innumerable foods. In No­ vember 1971 the FDA scientists decided that the evidence for carci­ nogenesis in animals...
Journal Article
South Atlantic Quarterly (2024) 123 (3): 637–645.
Published: 01 July 2024
... regulated through unnecessary restrictions mandated by the US Food and Drug Administration's (FDA) REMS program (ACOG 2023 ). The REMS policies are designed to regulate medications with such significant potential for addiction and/or toxicity that the FDA deems it necessary to restrict access...
Journal Article
South Atlantic Quarterly (2024) 123 (3): 623–629.
Published: 01 July 2024
... communities earlier (Rosing and Archibald, 2000 ), the 2000 FDA approval of mifepristone and misoprostol for ending unwanted pregnancies presented new options for feminist activism. In 2004, a small group of nonprofit leaders from the Abortion Access Project, the ACLU of Massachusetts, Gynuity Health...
Journal Article
South Atlantic Quarterly (2004) 103 (4): 769–811.
Published: 01 October 2004
... critical difference. By the late 1980s to mid-1990s, the discourse on HIV/AIDS, in South Africa 15 as elsewhere, had been altered by the emergence of ‘‘miracle drugs After the FDA approved Zidovudine (AZT) in 1987, it was clear that the medi- 772 Adam Sitze cation, while toxic...
Journal Article
South Atlantic Quarterly (2025) 124 (2): 225–262.
Published: 01 April 2025
... Therapy .” Configurations 22 , no. 1 : 79 – 111 . Cvetkovich Ann . 2012 . Depression: A Public Feeling . Durham, NC : Duke University Press . Devenot Neşe . 2024 . “ MAPS/Lykos MDMA Application—FDA Public Comment Challengers .” PSymposia Channel, June 4. YouTube video, 31:49...